Multiple myeloma, version 1.2013. Academic Article

Overview

abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include the addition of new regimens as options for salvage therapy and strategies to mitigate the adverse effects and risks associated with newer regimens for the treatment of multiple myeloma.

authors

Anderson, Kenneth C

Alsina, Melissa

Bensinger, William

Biermann, J Sybil

Djulbegovic, Benjamin

Faber, Edward A

Gasparetto, Cristina

Hernandez-Illizaliturri, Francisco

Huff, Carol Ann

Kassim, Adetola

Krishnan, Amrita Y

Liedtke, Michael

Schriber, Jeffrey

Stockerl-Goldstein, Keith

Treon, Steven P

Yahalom, Joachim
Yunus, Furhan
Shead, Dorothy A
Kumar, Rashmi

publication date

January 1, 2013

published in

Journal of the National Comprehensive Cancer Network : JNCCN Journal

Research

keywords

Antineoplastic Agents
Multiple Myeloma
Practice Guidelines as Topic
Salvage Therapy

Identity

PubMed ID

23307977

Additional Document Info

volume

11

issue

1